Surgery pp 2097-2116 | Cite as

Head and Neck Malignancies

  • Jeffrey S. Moyer
  • Carol R. Bradford


Head and neck cancer accounts for 4% of all new cancer cases and 2% of all cancer deaths in the United States annually. This statement translates into 40,000 new diagnoses of head and neck cancer (30,300 with oral cavity and pharyngeal cancer and 12,500 with laryngeal cancer).1 Head and neck cancer has a much greater incidence in certain parts of the world, particularly in India, and is a leading cause of cancer mortality worldwide.2


Neck Cancer Human Papilloma Virus Neck Dissection Organ Preservation Human Papilloma Virus Type 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boring CC, Squires TS, Tong T, et al. Cancer Statistics 1992;42:19.Google Scholar
  2. 2.
    Decker J, Goldstein JD. Risk factors in head and neck cancer. N Engl J Med 1982;306:1151.PubMedGoogle Scholar
  3. 3.
    Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease [editorial]. Int J Radiat Oncol BiolPhys 1989;17:691.CrossRefGoogle Scholar
  4. 4.
    Wynder EL, Hoffman D. Tobacco. In: Schottenfield D, Fraumeri JF Jr, eds. Cancer Epidemiology and Prevention. Philadelphia: Saunders, 1982:277–292.Google Scholar
  5. 5.
    Boyle P, Macfarlane GJ, McGinn R, et al. International epidemiology of head and neck cancer. In: de Vries N, Gluckman JL, eds. Primary Tumors in the Head and Neck. Stuttgart: Thieme, 1990:80–138.Google Scholar
  6. 6.
    Caplan GA, Brigham BA. Marijuana smoking and carcinoma of the tongue: is there an association? Cancer (Phila) 1990;66:1005.PubMedCrossRefGoogle Scholar
  7. 7.
    Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1998;48:3282.Google Scholar
  8. 8.
    Paz B, Cook N, Odom-Maryon T, et al. Human papillomavirus (HPV) in head and neck cancer. Cancer (Phila) 1997;79:595–604.PubMedCrossRefGoogle Scholar
  9. 9.
    Snijders PJF, Cromme FV, Van Den Brule AJC, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992;51:845–850.PubMedCrossRefGoogle Scholar
  10. 10.
    Clayman GL, Stewart MG, Weber RS, et al. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 1994;120:743–748.PubMedGoogle Scholar
  11. 11.
    Kashima HK, Kutcher M, Kessis T, et al. Human papillomavirus in squamous cell carcinoma, leukoplakia, lichen planus, and clinically normal epithelium of the oral cavity. Ann Otol Rhinol Laryngol 1990;99:55–61.PubMedGoogle Scholar
  12. 12.
    De Villers EM, Weidauer H, Otto H, et al. Papillomavirus DNA in human tongue carcinomas. Int J Cancer 1985;36:575–578.CrossRefGoogle Scholar
  13. 13.
    Hording U, Nielsen HW, Daugaard S, et al. Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction. Laryngoscope 1994;104:99–102.PubMedGoogle Scholar
  14. 14.
    Bradford CR, Zacks SE, Androphy EJ, et al. Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 1991;104:303–310.PubMedGoogle Scholar
  15. 15.
    Beck JC, McClatchey KD, Lesperance MM, et al. Human papillomavirus types important in progression of inverted papilloma. Otolaryngol Head Neck Surg 1995;113:558–563.PubMedCrossRefGoogle Scholar
  16. 16.
    Fouret P, Martin F, Flahault A, et al. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol 1995;4:122–127.PubMedCrossRefGoogle Scholar
  17. 17.
    Miller CS, White DK. Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 1996;82:58–68.Google Scholar
  18. 18.
    Steinberg BM, DiLorenzi TP. A possible role for human papilloma virus in head and neck cancer. Cancer Metastasis Rev 1996;15:91–112.PubMedCrossRefGoogle Scholar
  19. 19.
    Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998;90:1626–1636.PubMedCrossRefGoogle Scholar
  20. 20.
    Connors JM, Jacobs C. Nasopharyngeal carcinoma: relationship to Epstein-Barr virus and treatment with interferon. In: Jacob CJ, ed. Cancers of the Head and Neck. Boston: Martinus Nijhoff, 1987:167–175.Google Scholar
  21. 21.
    Raab-Traub N, Flynn K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 1987;39:25.PubMedCrossRefGoogle Scholar
  22. 22.
    Henderson BE, Louis E, SooHoo Jing J, et al. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med 1997;295:1101.Google Scholar
  23. 23.
    Graham S. Epidemiology of retinoids and cancer. J Natl Cancer Inst 1984;73:1423.PubMedGoogle Scholar
  24. 24.
    Lippman SM, Meyskens FL. Retinoids for the prevention of cancer. In: Moon TE, Micozzi M, eds. Nutrition and Cancer Prevention: The Role of Micronutrients. New York: Dekker, 1989:243–272.Google Scholar
  25. 25.
    McLaughlin JK, Gridley G, Block G, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80:1237.PubMedCrossRefGoogle Scholar
  26. 26.
    Jain S, Khuri FR, Shin DM. Prevention of head and neck cancer: current status and future prospects. Curr Probl Cancer 2004;28(5):265.PubMedCrossRefGoogle Scholar
  27. 27.
    Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005;97(7):481.PubMedGoogle Scholar
  28. 28.
    Goolden AWG. Radiation cancer: a review with special reference to radiation tumors in the pharynx, larynx, and thyroid. Br J Radiol 1957;30:626.PubMedCrossRefGoogle Scholar
  29. 29.
    Barton RT, Hogetveit AC. Nickel-related cancers of the respiratory tract. Cancer (Phila) 1980;45:3061.PubMedCrossRefGoogle Scholar
  30. 30.
    Cann CI, Fried MP, Rotman KJ. Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin N Am 1985;18:367.Google Scholar
  31. 31.
    American Joint Committee on Cancer. AJCC Cancer Staging Handbook, 6th ed. New York: Springer, 2002.Google Scholar
  32. 32.
    Jakobsson PA, Erneroth DM, Killander D, et al. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 1973;12:1.PubMedGoogle Scholar
  33. 33.
    Cooper JS, Pajak TF, Forastiere A. Precisely defining high-risk operable head and neck tumors based on RTOG: 85093 and RTOG:88-24: targets for postoperative radiochemotherapy? Head Neck 1998;20:588–594.PubMedCrossRefGoogle Scholar
  34. 34.
    Bradford CR, Wolf GT, Carey TE, et al. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma. Otolaryngol Head Neck Surg, 1999;121:534–538.PubMedCrossRefGoogle Scholar
  35. 35.
    Mashberg AL. Erythoplasia vs. leukoplakia in the diagnosis of early asymptomatic oral squamous carcinoma. N Engl J Med 1977;297:109.PubMedCrossRefGoogle Scholar
  36. 36.
    Jacobs C. The internist in the management of head and neck cancer. Ann Intern Med 1990;113:771.PubMedGoogle Scholar
  37. 37.
    American Society for Head and Neck Surgery and the Society of Head and Neck Surgeons. Cancer of the Head and Neck: Clinical Practice Guidelines. 1996. Available at: Scholar
  38. 38.
    Arunachalam PS, Putnam G, Jennings P, et al. Role of computerized tomography (CT) scan of the chest in patients with newly diagnosed head and neck cancers. Clin Otolaryngol 2002;27(5):409.PubMedCrossRefGoogle Scholar
  39. 39.
    Warner GC, Cox GJ. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. J Otolaryngol 2003;32(2):107.PubMedCrossRefGoogle Scholar
  40. 40.
    Byers RM, Bland KI, Borlase B, et al. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg 1978;136:525–528.PubMedCrossRefGoogle Scholar
  41. 41.
    Bauer WC, Lesinski SG, Ogura JH. The significance of positive margins in hemilaryngectomy specimens. Laryngoscope 1975;85:1–13.PubMedCrossRefGoogle Scholar
  42. 42.
    Batsakis JG. Surgical margins in squamous cell carcinomas. Ann Otol Rhinol Laryngol 1988;97:213–214.PubMedGoogle Scholar
  43. 43.
    Looser KG, Shah JP, Strong EW. The significance of “positive” margins in surgically resected epidermoid carcinomas. Head Neck Surg 1978;1:107–111.PubMedCrossRefGoogle Scholar
  44. 44.
    Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol-Head Neck Surg 2002;128(7):751–758.PubMedGoogle Scholar
  45. 45.
    Kramer S, Gelber RD, Snow JB, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of the study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19.PubMedCrossRefGoogle Scholar
  46. 46.
    Vikram B, Strong EW, Shah J, et al. Elective postoperative irradiation in stages III and IV epidermioid carcinoma of the head and neck. Am J Surg 1980;140:580.PubMedCrossRefGoogle Scholar
  47. 47.
    Stuscke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1997;37:259.Google Scholar
  48. 48.
    Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798–1804.PubMedCrossRefGoogle Scholar
  49. 49.
    Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695.PubMedGoogle Scholar
  50. 50.
    Laramore GE. Radiation Therapy of Head and Neck Cancer. Berlin: Springer-Verlag, 1988.Google Scholar
  51. 51.
    Wolf GT, Lippman SM, Laramore GE, Hong WK. Head and neck cancer. In: Holland JF, Frei E, eds. Cancer Medicine. Philadelphia: Lea & Febieger, 1993:1211–1274.Google Scholar
  52. 52.
    Wolf GT, Hong WK, Fisher SG, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685–1690.Google Scholar
  53. 53.
    Lefebvre J-L, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996;88:890–899.PubMedCrossRefGoogle Scholar
  54. 54.
    Richard JM, Sancho-Garnier H, Pessey JJ, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 1998;34:224–228.PubMedCrossRefGoogle Scholar
  55. 55.
    Calais G, Alfonsi M, Bardet E, et al.: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-staged oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081.PubMedCrossRefGoogle Scholar
  56. 56.
    Schuller DE, Stein DW, Metch B. Analysis of treatment failure patterns: a Southwest Oncology Group study. Arch Otolaryngol Head Neck Surg 1989;115:834–836.PubMedGoogle Scholar
  57. 57.
    Laramore GE, Scott CB, al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup 0035. Int J Radiat Oncol Biol Phys 1992;23:885–886.Google Scholar
  58. 58.
    Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091.PubMedCrossRefGoogle Scholar
  59. 59.
    Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy in high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937.PubMedCrossRefGoogle Scholar
  60. 60.
    Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945.PubMedCrossRefGoogle Scholar
  61. 61.
    Lefebvre JL, Wolf GT, Luboinski B, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (2) larynx preservation using neoadjuvant chemotherapy in laryngeal and hypopharyngeal carcinoma [abstract]. 1998. Proc Am Soc Clin Oncol 1998;17:382a.Google Scholar
  62. 62.
    Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949–955.PubMedGoogle Scholar
  63. 63.
    Browman GP, Hodson DI, Mackenzie RJ, et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579.PubMedCrossRefGoogle Scholar
  64. 64.
    Urba SG, Wolf GT, Bradford CR, et al. Neoadjuvant therapy for organ preservation in head and neck cancer. Laryngoscope 2000;110(12):2074.PubMedCrossRefGoogle Scholar
  65. 65.
    Urba S, Worden F, Carey T, et al. One cycle of induction chemotherapy to select for organ preservation for patients with advanced squamous carcinoma of the oral cavity [abstract]. J Clin Oncol 2005;23(suppl):61s (abstract 5555).Google Scholar
  66. 66.
    Spiro RH, Alfonso AE, Farr HW, et al. Cervical node metastases from epidermoid carcinoma of the oral cavity and oropharynx: a critical assessment of current staging. Am J Surg 1974;128:562.PubMedCrossRefGoogle Scholar
  67. 67.
    Spiro RH, Huvos AG, Wong GY, et al. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986;152(4):345.PubMedCrossRefGoogle Scholar
  68. 68.
    Bradford CR, Chepeha DB. Microvascular free flaps in head and neck reconstruction. In: Bailey BJ, Calhoun KH, eds. Head and Neck Surgery-Otolaryngology, 2nd ed. Philadelphia: Lippin-cott-Raven 1998:2389–2410.Google Scholar
  69. 69.
    DiTroia JF. Nodal metastases and prognosis in carcinoma of the oral cavity. Otolaryngol Clin N Am 1972;5:333.Google Scholar
  70. 70.
    Baker SR. Malignant neoplasms of the oral cavity. In: Cummings CW, Frederickson JM, Harker LA, et al, eds. Otolaryngology-Head and Neck Surgery, 1st ed. St. Louis: Mosby, 1986:1281–1344.Google Scholar
  71. 71.
    Bradford CR, Krause CJ. Floor of mouth cancer. In: Gates G, ed. Current Therapy of Head and Neck Cancer, 5th ed. St. Louis: Mosby 1994:266–267.Google Scholar
  72. 72.
    Esclamado RM, Burkey BB, Carroll WR, et al. The platysma myocutaneous flap: indications and caveats. Arch Otolaryngol Head Neck Surg 1994;120:32–35.PubMedGoogle Scholar
  73. 73.
    Strome SE, To Waiyat, Strawderman M, Gerstin K, Bradford CR, Esclamado RM. Squamous cell carcinoma of the buccal mucosa. Otolaryngol Head Neck Surg 1999;120(3):375–379.PubMedCrossRefGoogle Scholar
  74. 74.
    Worden FP, Urba S, Bradford C, et al. One cycle of induction chemotherpay in advanced oropharyngeal cancer to select patients for organ preservation [abstract]. J Clin Oncol 2005;23(suppl):61s (abstract 5512).Google Scholar
  75. 75.
    Bradford CR, Futran N, Peters G. Controversies: management of tonsil cancer. Head Neck 1999;21:657–662.PubMedCrossRefGoogle Scholar
  76. 76.
    O’Brien CJ, Castle GK, Steven GN, et al. Limitations of radiotherapy in the definitive treatment of squamous carcinoma of the tonsillar fossa. Aust N Z J Surg 1992;62:709–713.PubMedCrossRefGoogle Scholar
  77. 77.
    Hicks WL, Kuriakose A, Loree TR, et al. Surgery versus radiation therapy as a single-modality treatment of tonsillar fossa carcinoma: the Roswell Park Cancer Institute experience. Laryngoscope 1998;108:1014–1019.PubMedCrossRefGoogle Scholar
  78. 78.
    Domenge C, Hill C, Lefebvre JL, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer 2000;83:1594.PubMedCrossRefGoogle Scholar
  79. 79.
    Stern SJ. Anatomy of the lateral pharyngotomy approach. Head Neck 1992;14:153–156.PubMedCrossRefGoogle Scholar
  80. 80.
    Zeitels SM, Vaughan CW, Toomey JM. A precision technique for suprahyoid pharyngotomy. Laryngoscope 1991;101:565–566.PubMedCrossRefGoogle Scholar
  81. 81.
    Sessions DG, Cummings CW, Weymuller EA, et al. Oropharynx. In: Atlas of Access & Reconstruction in Head and Neck Surgery. St. Louis: Mosby Year Book 1992:71–106.Google Scholar
  82. 82.
    Bradford CR, Esclamado RM, Carroll WR, et al. Analysis of recurrence, complications, and functional results with free jejunal flaps. Head Neck 1994:150–154.Google Scholar
  83. 83.
    Razack M, Sako K, Marchetta F, et al. Carcinoma of the hypo-pharynx: success and failure. Am J Surg 1977;134:489.PubMedCrossRefGoogle Scholar
  84. 84.
    DelGaudio JM, Fleming DJ, Esclamado RM, et al. Hemilaryngectomy for glottic carcinoma after radiation therapy failure. Arch Otolaryngol Head Neck Surg 1994;120:959–963.PubMedGoogle Scholar
  85. 85.
    Sassier AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy: analysis of wound complications. Arch Otolaryngol 1995;121:162–165.Google Scholar
  86. 86.
    Laccourreye H, Laccourreye O, Weinstein G. Supracricoid laryngectomy with cricohyoidoepiglottopexy: a partial laryngeal procedure for glottic carcinoma. Ann Otol Rhinol Laryngol 1990;99:421–426.PubMedGoogle Scholar
  87. 87.
    Zeitels SM, Koufman JA, Davis RK, et al. Endoscopic treatment of supraglottic and hypopharynx cancer. Laryngoscope 1994;104:71–78.PubMedCrossRefGoogle Scholar
  88. 88.
    Lutz CK, Wagner RL, Johnson JT, Myers EN. Supraglottic carcinoma: patterns of recurrence. Ann Otol Rhinol Laryngol 1990;99:12–17.PubMedGoogle Scholar
  89. 89.
    Silver C. The Larynx and Hypopharynx. In: Silver CE, ed. Atlas of Head and Neck Surgery. New York: Churchill Livingstone 1986:167–251.Google Scholar
  90. 90.
    Laccourreye H, Laccourreye O, Weinstein G, et al. Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope 1990;100:735–741.PubMedGoogle Scholar
  91. 91.
    Bradford CR, Wolf GT, Fisher SG, et al. Prognostic importance of surgical margins in advanced laryngeal squamous cell carcinoma. Head Neck 1996;18:11–16.PubMedCrossRefGoogle Scholar
  92. 92.
    Shanmugaratnam K, Path FRC, Sobin LH. The World Health Organization histological classification of tumors of the upper respiratory tract and ear: a commentary on the second edition. Cancer (Phila) 1993;71:2689–2697.PubMedCrossRefGoogle Scholar
  93. 93.
    Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer. J Clin Oncol 1998;16:1310–1317.PubMedGoogle Scholar
  94. 94.
    Beck JC, McClatchey KD, Bradford CR, et al. Human papillomavirus types important in progression of inverted papilloma. Otolaryngol Head Neck Surg 1995;113:558–563.PubMedCrossRefGoogle Scholar
  95. 95.
    Moyer JS, Chepeha DB, Teknos TN. Contemporary skull base reconstruction. Curr Opin Otolaryngol Head Neck Surg 2004;12:294–299.PubMedCrossRefGoogle Scholar
  96. 96.
    Sessions D, Cummings C, Weymuller E, et al., eds. Nasal cavity, paranasal sinuses, and anterior cranial fossa. In: Atlas of Access & Reconstruction in Head and Neck Surgery. St. Louis: Mosby Year Book 1992:107–162.Google Scholar
  97. 97.
    Price J, Holiday M, Johns M, et al. The versatile midfacial degloving approach. Laryngoscope 1988;98:291–295.PubMedGoogle Scholar
  98. 98.
    Moore CE, Marentette LJ, Ross D, et al. Subcranial approach to tumors of the anterior cranial base: analysis of current and traditional surgical techniques. Otolaryngol Head Neck Surg 1999;120:387–390.PubMedCrossRefGoogle Scholar
  99. 99.
    Isaacs J, Mooney S, Mendenhall W, et al. Cancer of the maxillary sinus treated with surgery and/or radiation therapy. Am Surg 1990;56:327.PubMedGoogle Scholar
  100. 100.
    Spaulding CA, Kranyak MS, Constable WC, et al. Esthesioneu-roblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988;15:581.PubMedGoogle Scholar
  101. 101.
    Eneroth C, Hamberger C. Principles of treatment of different types of parotid tumors. Laryngoscope 1974;84:1732.PubMedCrossRefGoogle Scholar
  102. 102.
    Johns M, Coulthard S. Survival and follow-up in malignant tumors of the salivary glands. Otolaryngol Clin N Am 1977;10:455.Google Scholar
  103. 103.
    Bjorkland A, Eneroth C. Management of parotid gland neoplasms. Am J Otolaryngol 1980;1:155.CrossRefGoogle Scholar
  104. 104.
    Batsakis JG. Tumors of the head and neck. In: Batsakis JG, ed. Clinical and Pathological Considerations. Baltimore: Williams & Wilkins, 1974.Google Scholar
  105. 105.
    Griffin T, Pajak T, Laramore G, et al. Neutron vs. photon irradiation of inoperable salivary gland tumors: results of an RTOG-MRC Cooperative Randomized Study. Int J Radiat Oncol Biol Phys 1988;15:1085.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Jeffrey S. Moyer
    • 1
    • 2
  • Carol R. Bradford
    • 3
    • 4
  1. 1.Department of OtolaryngologyUniversity of MichiganAnn ArborUSA
  2. 2.A. Alfred Taubman Health Care CenterUniversity of MichiganAnn ArborUSA
  3. 3.Head and Neck Cancer ClinicUniversity of Michigan, UM Comprehensive Cancer CenterAnn ArborUSA
  4. 4.Department of Otolaryngology/Head and Neck SurgeryUniversity of Michigan, UM Comprehensive Cancer CenterAnn ArborUSA

Personalised recommendations